Abstract:Background: Gastric cancer is one of the deadliest malignant tumours, with a high incidence in China, and is regulated by aberrantly overexpressed oncogenes. However, existing therapies are insufficient to meet patients' needs; thus, the identification of additional therapeutic targets and exploration of the underlying mechanism are urgently needed. GPAA1 is the subunit of the GPI transamidase that transfers the GPI anchor to proteins within the ER. The functional impacts of increased expression levels of GPAA1 in human cancers are not well understood. Methods: Data mining was performed to determine the pattern of GPAA1 expression and the reason for its overexpression in tumour and adjacent normal tissues. In vitro and in vivo experiments evaluating proliferation and metastasis were performed using cells with stable deletion or overexpression of GPAA1. A tissue microarray established by the Ren Ji Hospital was utilized to analyse the expression profile of GPAA1 and its correlation with prognosis. Western blotting, an in situ proximity ligation assay, and co-immunoprecipitation (co-IP) were performed to reveal the mechanism of GPAA1 in gastric cancer. Results: GPAA1 was a markedly upregulated oncogene in gastric cancer due to chromosomal amplification. GPAA1 overexpression was confirmed in specimens from the Ren Ji cohort and was associated with ERBB2 expression, predicting unsatisfactory patient outcomes. Aberrantly upregulated GPAA1 dramatically contributed to cancer growth and metastasis in in vitro and in vivo studies. Mechanistically, GPAA1 enhanced the levels of metastasis-associated GPI-anchored proteins to increase tumour metastasis and intensified lipid raft formation, which consequently promoted the interaction between EGFR and ERBB2 as well as downstream pro-proliferative signalling. Conclusions: GPAA1 facilitates the expression of cancer-related GPI-anchored proteins and supplies a more robust platform-the lipid raft-to promote EGFR-ERBB2 dimerization, which further contributes to tumour growth and metastasis and to cancer progression. GPAA1 could be a promising diagnostic biomarker and therapeutic target for gastric cancer.

GALNT1 Enhances Malignant Phenotype of Gastric Cancer Via Modulating CD44 Glycosylation to Activate the Wnt/β-catenin Signaling Pathway.

Polypeptide N -acetylgalactosaminyltransferase-6 expression in gastric cancer.

C1GALT1-mediated O-glycan T antigen increase enhances the migration and invasion ability of gastric cancer cells

ST6GALNAC4 Promotes Hepatocellular Carcinogenesis by Inducing Abnormal Glycosylation.

Expression Of N-Acetylglucosaminyltransferase V In Gastric Cancer Correlates With Metastasis And Prognosis

Β3gnt8 Promotes Gastric Cancer Invasion by Regulating the Glycosylation of CD147

Galactosyltransferase B4GALT1 confers chemoresistance in pancreatic ductal adenocarcinomas by upregulating N-linked glycosylation of CDK11p110.

O-GlcNAcylation of the Signaling Scaffold Protein, GNB2L1 Promotes Its Degradation and Increases Metastasis of Gastric Tumours.

Expression of Galectin-1 in Carcinoma-Associated Fibroblasts Promotes Gastric Cancer Cell Invasion Through Upregulation of Integrin Beta 1

Polypeptide N-Acetylgalactosaminyltransferase 2 Regulates Cellular Metastasis-Associated Behavior In Gastric Cancer

GALNT14-mediated O-glycosylation drives lung adenocarcinoma progression by reducing endogenous reactive oxygen species generation

Downregulation of the Gnt-V Gene Inhibits Metastasis and Invasion of Bgc823 Gastric Cancer Cells

C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin αv

N-acetylgalactosaminyltransferase GALNT6 is a potential therapeutic target of clear cell renal cell carcinoma progression

Galnt6 Promotes Tumorigenicity And Metastasis Of Breast Cancer Cell Via Beta-Catenin/Muc1-C Signaling Pathway

Mucin O-glycosylating Enzyme GALNT2 Facilitates the Malignant Character of Glioma by Activating the EGFR/PI3K/Akt/mTOR Axis.

GNB2L1 and Its O-GlcNAcylation Regulates Metastasis Via Modulating Epithelial-Mesenchymal Transition in the Chemoresistance of Gastric Cancer.

LAMTOR5 raises abnormal initiation of O-glycosylation in breast cancer metastasis via modulating GALNT1 activity

N‐glycosylation by N‐acetylglucosaminyltransferase V Enhances the Interaction of CD147/basigin with Integrin Β1 and Promotes HCC Metastasis

The polypeptide N-acetylgalactosaminyltransferase 4 exhibits stage-dependent expression in colorectal cancer and affects tumorigenesis, invasion and differentiation

GPAA1 Promotes Gastric Cancer Progression Via Upregulation of GPI-anchored Protein and Enhancement of ERBB Signalling Pathway